Anthony E. Oro - Related publications

Stanford University, Palo Alto, CA 
Oncology, Cell Biology, Biochemistry
NOTE: We are testing a new system for identifying relevant work based on semantic analysis that identifies similarities between recently published papers and the current author's publications. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches.
26 most relevant papers in past 60 days:
Year Citation  Score
2022 Peng ZP, Huang SF, Li JJ, Tang XK, Wang XY, Li HM. The Effects of Hedgehog Signaling Pathway on the Proliferation and Apoptosis of Melanoma Cells. Journal of Oncology. 2022: 4984866. PMID 35027924 DOI: 10.1155/2022/4984866   
2022 Chen P, Hu J, Han X, Chen Y. Advances in the functional roles of N6-methyladenosine modification in cancer progression: mechanisms and clinical implications. Molecular Biology Reports. PMID 35025029 DOI: 10.1007/s11033-022-07126-5   
2022 Xie G, Peng Z, Liang J, Larabee SM, Drachenberg CB, Yfantis H, Raufman JP. Zinc finger protein 277 is an intestinal transit-amplifying cell marker and colon cancer oncogene. Jci Insight. PMID 35015732 DOI: 10.1172/jci.insight.150894   
2022 Bolatkan A, Asada K, Kaneko S, Suvarna K, Ikawa N, Machino H, Komatsu M, Shiina S, Hamamoto R. Downregulation of METTL6 mitigates cell progression, migration, invasion and adhesion in hepatocellular carcinoma by inhibiting cell adhesion molecules. International Journal of Oncology. 60. PMID 34913069 DOI: 10.3892/ijo.2021.5294   
2022 Weiss F, Lauffenburger D, Friedl P. Towards targeting of shared mechanisms of cancer metastasis and therapy resistance. Nature Reviews. Cancer. PMID 35013601 DOI: 10.1038/s41568-021-00427-0   
2022 Wang H, Fan Y, Chen W, Lv Z, Wu S, Xuan Y, Wang C, Lu Y, Guo T, Shen D, Zhang F, Huang Q, Gao Y, Li H, Ma X, et al. Loss of CMTM6 promotes DNA damage-induced cellular senescence and antitumor immunity. Oncoimmunology. 11: 2011673. PMID 35024247 DOI: 10.1080/2162402X.2021.2011673   
2022 Xie XP, Laks DR, Sun D, Ganbold M, Wang Z, Pedraza AM, Bale T, Tabar V, Brennan C, Zhou X, Parada LF. Quiescent human glioblastoma cancer stem cells drive tumor initiation, expansion, and recurrence following chemotherapy. Developmental Cell. 57: 32-46.e8. PMID 35016005 DOI: 10.1016/j.devcel.2021.12.007   
2022 Li B, Xiao Q, Shan L, Song Y. NCAPH promotes cell proliferation and inhibits cell apoptosis of bladder cancer cells through MEK/ERK signaling pathway. Cell Cycle (Georgetown, Tex.). 1-12. PMID 34974790 DOI: 10.1080/15384101.2021.2021050   
2022 Yang H, Wang L, Zheng Y, Hu G, Ma H, Shen L. Knockdown of zinc finger protein 267 suppresses diffuse large B-cell lymphoma progression, metastasis, and cancer stem cell properties. Bioengineered. 13: 1686-1701. PMID 35001816 DOI: 10.1080/21655979.2021.2014644   
2022 Cackowski FC, Heath EI. Prostate cancer dormancy and recurrence. Cancer Letters. 524: 103-108. PMID 34624433 DOI: 10.1016/j.canlet.2021.09.037   
2022 Lee U, Cho EY, Jho EH. Regulation of Hippo signaling by metabolic pathways in cancer. Biochimica Et Biophysica Acta. Molecular Cell Research. 119201. PMID 35026349 DOI: 10.1016/j.bbamcr.2021.119201   
2022 Han Z, Gong C, Li J, Guo H, Chen X, Jin Y, Gao S, Tai Z. Immunologically modified enzyme-responsive micelles regulate the tumor microenvironment for cancer immunotherapy. Materials Today. Bio. 13: 100170. PMID 34938989 DOI: 10.1016/j.mtbio.2021.100170   
2022 Wei P, Jiang J, Xiao M, Zeng M, Liu X, Zhao B, Chen F. The transcript ENST00000444125 of lncRNA LINC01503 promotes cancer stem cell properties of glioblastoma cells via reducing FBXW1 mediated GLI2 degradation. Experimental Cell Research. 113009. PMID 34990616 DOI: 10.1016/j.yexcr.2022.113009   
2022 Lee JM, Kim HS, Kim A, Chang YS, Lee JG, Cho J, Kim EY. ABT-737, a BH3 Mimetic, Enhances the Therapeutic Effects of Ionizing Radiation in K-ras Mutant Non-Small Cell Lung Cancer Preclinical Model. Yonsei Medical Journal. 63: 16-25. PMID 34913280 DOI: 10.3349/ymj.2022.63.1.16   
2022 Wang D, Sun L, Okuda S, Yamamoto D, Nakayama M, Oshima H, Saito H, Kouyama Y, Mimori K, Ando T, Watanabe S, Oshima M. Nano-scale physical properties characteristic to metastatic intestinal cancer cells identified by high-speed scanning ion conductance microscope. Biomaterials. 280: 121256. PMID 34794825 DOI: 10.1016/j.biomaterials.2021.121256   
2022 Nie X, Liu H, Ye W, Wei X, Fan L, Ma H, Li L, Xue W, Qi W, Wang YD, Chen WD. LRP5 promotes cancer stem cell traits and chemoresistance in colorectal cancer. Journal of Cellular and Molecular Medicine. PMID 34997691 DOI: 10.1111/jcmm.17164   
2022 Zhang J, Yang Y, Dong Y, Liu C. Microrchidia family CW‑type zinc finger 2 promotes the proliferation, invasion, migration and epithelial‑mesenchymal transition of glioma by regulating PTEN/PI3K/AKT signaling via binding to N‑myc downstream regulated gene 1 promoter. International Journal of Molecular Medicine. 49. PMID 34913078 DOI: 10.3892/ijmm.2021.5071   
2022 Wang K, Patkar S, Lee JS, Gertz EM, Robinson W, Schischlik F, Crawford DR, Schaffer AA, Ruppin E. Deconvolving clinically relevant cellular immune crosstalk from bulk gene expression using CODEFACS and LIRICS stratifies melanoma patients to anti-PD-1 therapy. Cancer Discovery. PMID 34983745 DOI: 10.1158/2159-8290.CD-21-0887   
2022 Lee HJ, Min HY, Yong YS, Ann J, Nguyen CT, La MT, Hyun SY, Le HT, Kim H, Kwon H, Nam G, Park HJ, Lee J, Lee HY. A novel C-terminal heat shock protein 90 inhibitor that overcomes STAT3-Wnt-β-catenin signaling-mediated drug resistance and adverse effects. Theranostics. 12: 105-125. PMID 34987637 DOI: 10.7150/thno.63788   
2022 Guo T, Zhang Z, Zhu L, Chen W, Ding Y, Li W, Huang Y, Huang J, Pan X. TRIM55 suppresses malignant biological behavior of lung adenocarcinoma cells by increasing protein degradation of Snail1. Cancer Biology & Therapy. 1-10. PMID 34974792 DOI: 10.1080/15384047.2021.2004835   
2022 Yang Y, Li L, He H, Shi M, He L, Liang S, Qi J, Chen W. Numb inhibits migration and promotes proliferation of colon cancer cells via RhoA/ROCK signaling pathway repression. Experimental Cell Research. 411: 113004. PMID 34990618 DOI: 10.1016/j.yexcr.2021.113004   
2022 Dey A, Sharp DJ. In Vitro Screening Assay for Activators of T-Cell Migration to Solid Tumors. Methods in Molecular Biology (Clifton, N.J.). 2423: 109-113. PMID 34978693 DOI: 10.1007/978-1-0716-1952-0_11   
2022 Bley IA, Zwick A, Hans MC, Thieser K, Wagner V, Ludwig N, Khalmurzaev O, Matveev VB, Loertzer P, Pryalukhin A, Hartmann A, Geppert CI, Loertzer H, Wunderlich H, Naumann CM, et al. DKK1 inhibits canonical Wnt signaling in human papillomavirus-positive penile cancer cells. Translational Oncology. 15: 101267. PMID 34773828 DOI: 10.1016/j.tranon.2021.101267   
2022 Kono M, Komatsuda H, Yamaki H, Kumai T, Hayashi R, Wakisaka R, Nagato T, Ohkuri T, Kosaka A, Ohara K, Kishibe K, Takahara M, Katada A, Hayashi T, Kobayashi H, et al. Immunomodulation via FGFR inhibition augments FGFR1 targeting T-cell based antitumor immunotherapy for head and neck squamous cell carcinoma. Oncoimmunology. 11: 2021619. PMID 35003900 DOI: 10.1080/2162402X.2021.2021619   
2022 Kim SY, Hwang S, Lee BR, Hong JA, Sung YH, Kim I. Inhibition of histone demethylase KDM4 by ML324 induces apoptosis through the unfolded protein response and Bim upregulation in hepatocellular carcinoma cells. Chemico-Biological Interactions. 353: 109806. PMID 34999051 DOI: 10.1016/j.cbi.2022.109806   
2022 Li L, Hu Y, Chen D, Zhu J, Bao W, Xu X, Chen H, Chen W, Feng R. CMTM5 inhibits the development of prostate cancer via the EGFR/PI3K/AKT signaling pathway. Molecular Medicine Reports. 25. PMID 34791506 DOI: 10.3892/mmr.2021.12533